LOGIN  |  REGISTER
Assertio

Brookdale Senior Living Reports June 2023 Occupancy

July 11, 2023 | Last Trade: US$8.83 0.11 1.26

NASHVILLE, Tenn., July 11, 2023 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) reported today its consolidated occupancy for June 2023.

Brookdale’s Consolidated Occupancy

June 2023 Observations:

  • June weighted average occupancy increased 160 basis points year-over-year, from 75.2% in 2022 to 76.8% in 2023. This represented a 20 basis point sequential increase compared to May 2023.
  • Achieved twenty consecutive months of year-over-year weighted average occupancy growth.
  • Weighted average occupancy increased sequentially each month within the quarter and the second quarter weighted average occupancy of 76.5% represented 190 basis points of year-over-year growth and 20 basis points of sequential growth compared to the first quarter 2023.

About Brookdale Senior Living

Brookdale Senior Living Inc. is the nation's premier operator of senior living communities. The Company is committed to its mission of enriching the lives of the people it serves with compassion, respect, excellence, and integrity. The Company, through its affiliates, operates independent living, assisted living, memory care, and continuing care retirement communities. Through its comprehensive network, Brookdale helps to provide seniors with care and services in an environment that feels like home. The Company's expertise in healthcare, hospitality, and real estate provides residents with opportunities to improve wellness, pursue passions, and stay connected with friends and loved ones. Brookdale, through its affiliates, operates and manages 672 communities in 41 states as of June 30, 2023, with the ability to serve more than 60,000 residents. Brookdale's stock trades on the New York Stock Exchange under the ticker symbol BKD. For more information, visit brookdale.com or connect with Brookdale on Facebook or Twitter.

 

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page